Literature DB >> 16904077

Allele-specific MMP-3 transcription under in vivo conditions.

Chaoyong Zhu1, Jacob Odeberg, Anders Hamsten, Per Eriksson.   

Abstract

A common matrix metalloproteinases-3 (MMP-3) -1612 5A/6A promoter polymorphism is associated with risk for cardiovascular disease, rheumatoid arthritis, and other diseases. Here we used the haplotype chromatin immunoprecipitation method to study allele-specific MMP-3 expression under in vivo conditions in heterozygous THP-1 cells. Pyrosequencing was used to analyse the ratio of 5A-allele to 6A-allele after chromatin immunoprecipitation using an antibody against phosphorylated active RNA polymerase II. There was no allele-specific difference in transcriptional activity during basal conditions, i.e., in unstimulated monocytic THP-1 cells. However, after stimulation of MMP-3 expression by monocyte differentiation or incubation with IL-1beta, the haplotype containing the 5A-allele was associated with higher transcriptional activity compared with the 6A-containing haplotype. Electromobility shift assay demonstrated increased binding of nuclear proteins to the 5A-allele after monocyte differentiation. In conclusion, the common MMP-3 5A/6A promoter polymorphism appears to be functional only during specific environmental conditions involving inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904077     DOI: 10.1016/j.bbrc.2006.07.174

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Allele-specific gene expression in a wild nonhuman primate population.

Authors:  J Tung; M Y Akinyi; S Mutura; J Altmann; G A Wray; S C Alberts
Journal:  Mol Ecol       Date:  2011-01-13       Impact factor: 6.185

2.  Association between matrix metalloproteinase family gene polymorphisms and ischemic stroke: a meta-analysis.

Authors:  Dan Wen; Xin Du; Shao-Ping Nie; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  Mol Neurobiol       Date:  2014-04-26       Impact factor: 5.590

3.  Functional Significance of MMP3 and TIMP2 Polymorphisms in Cleft Lip/Palate.

Authors:  A Letra; M Zhao; R M Silva; A R Vieira; J T Hecht
Journal:  J Dent Res       Date:  2014-05-05       Impact factor: 6.116

4.  Association of MMP-3 (-1612 5A/6A) polymorphism with knee osteoarthritis in Thai population.

Authors:  Sittisak Honsawek; Somkiat Malila; Pongsak Yuktanandana; Aree Tanavalee; Benjamad Deepaisarnsakul; Javad Parvizi
Journal:  Rheumatol Int       Date:  2012-03-29       Impact factor: 2.631

5.  Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB.

Authors:  Veronika Souslova; Paul A Townsend; Jelena Mann; Chris M van der Loos; Anna Motterle; Fulvio D'Acquisto; Derek A Mann; Shu Ye
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

6.  NF-kappaB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter.

Authors:  Ruth C Borghaei; Grzegorz Gorski; Masoud Javadi
Journal:  Biochem Biophys Res Commun       Date:  2009-03-09       Impact factor: 3.575

7.  Risk of coronary artery stenosis in Iranian type 2 diabetics: is there a role for matrix metalloproteinase-3 gene (-1612 5A/6A) polymorphism?

Authors:  Soudabeh Fallah; Morteza Seifi; Ali Samadikuchaksaraei
Journal:  J Physiol Biochem       Date:  2010-08-26       Impact factor: 4.158

8.  Matrix metalloproteinase gene polymorphisms in patients with rheumatoid arthritis.

Authors:  Sabrina Scherer; Thais Barboza de Souza; Juliana de Paoli; Claiton Viegas Brenol; Ricardo Machado Xavier; João Carlos Tavares Brenol; José Artur Chies; Daniel Simon
Journal:  Rheumatol Int       Date:  2009-06-06       Impact factor: 2.631

9.  Genomic features that predict allelic imbalance in humans suggest patterns of constraint on gene expression variation.

Authors:  Jenny Tung; Olivier Fédrigo; Ralph Haygood; Sayan Mukherjee; Gregory A Wray
Journal:  Mol Biol Evol       Date:  2009-06-08       Impact factor: 16.240

10.  Allelic gene expression imbalance of bovine IGF2, LEP and CCL2 genes in liver, kidney and pituitary.

Authors:  R Olbromski; E Siadkowska; B Zelazowska; L Zwierzchowski
Journal:  Mol Biol Rep       Date:  2012-11-25       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.